100+ UK business leaders demand Government action to help biotechnology companies seed, scale and stay in Britain

On 17th November 2026, a letter supported by more than 100 businesses, manufacturers, investors and organisations from across the UK bio-based sector was delivered to No 10 Downing Street.  The signatories call on the UK Government to ensure that biotechnologies invented in Britain are scaled, manufactured and commercialised here.

Led by the Bio-based and Biodegradable Industries Association (BBIA) and the BioRevolution Coalition, the Made by British Bio letter is backed by signatories representing more than £4.4 billion in combined revenues and over 35,000 UK jobs. They include Biome Technologies, Celtic Renewables, Croda, Ensus, Futamura, Ingenza, Modern Synthesis, Notpla, the REA, Twig Bio and Xampla.

The letter warns that the UK risks losing the economic benefits of its world-leading research. Despite the Government’s £2 billion, ten-year commitment to engineering biology, high capital costs, limited scale-up infrastructure, uncertain markets and regulation designed around fossil-based industries continue to drive British innovation and manufacturing overseas.

A £500 billion opportunity

The UK’s bioeconomy already contributes around £325 billion in gross value added and supports 6.4 million jobs, the fourth largest in Europe. Yet the UK ranks only 21st out of 28 European countries for bioeconomy growth. With the right investment and policy support, it is estimated that its annual contribution could reach £500 billion by 2030. The opportunity reaches far beyond healthcare, transforming how everyday products are made – from chemicals, cosmetics and cleaning products to packaging, textiles, food ingredients, fuels and construction materials – and extends to every region of the UK.

Dr Jen Vanderhoven, CEO of BBIA and Founder of the BioRevolution Coalition, said: “Britain has invested in science. Now we need to capture the manufacturing. Too often, the technologies we invent and develop here are being scaled and manufactured overseas. This is about much more than biotechnology. It is about reindustrialising Britain, creating skilled jobs in every region, strengthening our supply chains and reducing our dependence on imported fossil resources. Our UK industry is ready to invest, innovate and manufacture.

We are calling on the Government to match that ambition with clear leadership, investment in scale-up, fairer regulation and policies that create markets for British bio-based products. Our message is simple: Seed in Britain. Scale in Britain. Stay in Britain.”

Four actions for Government

The coalition is calling on Government to:

1. Put someone in charge – establish clear ministerial leadership and cross-government coordination for the bioeconomy.

2. Make the UK the best place to scale and manufacture – rapidly deploy the committed £186 million Engineering Biology Infrastructure Programme and introduce targeted support for first-of-a-kind UK biomanufacturing plants.

3. Level the playing field between fossil and renewable carbon – review taxation, regulation and carbon accounting, so that sustainable renewable carbon can compete fairly with virgin fossil carbon.

4. Create markets for British bio-based products – use the purchasing power of Government, the NHS and the wider public sector to create early demand.

As a first step, the signatories are asking the Government to urgently convene a high-level, cross-government roundtable with Ministers, senior officials, industry leaders and investors to agree a coordinated programme of action.

The letter follows a parliamentary petition, signed by more than 1,000 people, calling for an urgent review of how bio-based products are treated across UK policy, regulation and taxation.

Damian Kelly, Vice President, Innovation & Technology Development, Croda, said: “Biotechnology is creating exciting opportunities to transform the way we manufacture the ingredients and materials used in everyday products, from personal care and cosmetics to drug delivery technology for medicines and vaccines. For industry, the opportunity goes beyond replacing fossil-derived ingredients. It is about developing high-performance, sustainable products that can compete commercially in global markets. But to realise that potential, we need policies that recognise the value of renewable carbon, support innovation through to industrial scale and create the conditions for investment in British manufacturing. The UK has scientific expertise, industrial capabilities and talent. We now need to ensure that the next generation of bio-based products can be developed, scaled and manufactured here.”

Paul Mines, CEO, Biome Technologies and Chair, BBIA, said: “British companies are already developing innovative bio-based alternatives to fossil-derived chemicals and materials. The technology exists, the ambition exists and the market opportunity is enormous. What is missing is a policy and investment environment that allows these businesses to compete and manufacture at scale. For SMEs, the barriers are very real: high capital costs, limited scale-up infrastructure, uncertain markets and policies that too often favour established fossil-based products. We need a level playing field that recognises the full environmental benefits of renewable carbon, alongside Government procurement that helps create demand for British-made bio-based products. If we want these businesses to manufacture, invest and create jobs in Britain, we must make Britain the best place for them to do so. We are ready to invest, innovate, manufacture and grow. We ask the Government to create the conditions for us to do it here in Britain.”

Jenny Grant, Head of Organics and Natural Capital at the REA said: “We support the Made by British Bio campaign because biomanufacturing can transform how a range of everyday products are made, including developing pathways for using sustainable renewable carbon. By creating a coordinated programme of action, Britain can unlock more value from bio-based resources, improve its economic performance, and accelerate the transition to a more sustainable, circular and future-ready economy.”